Vertex Pharmaceuticals (VRTX) Current Leases (2012 - 2018)

Vertex Pharmaceuticals has reported Current Leases for 7 years, with the latest figure at $9.8 million in Q4 2018.

• For the quarter ending Q4 2018, Current Leases fell 56.43% year-over-year to $9.8 million; the trailing twelve-month figure through Dec 2018 stood at $9.8 million (down 56.43% YoY), and the FY2018 full-year result was $9.8 million, down 56.43% from the prior year.
• Current Leases for Q4 2018 stood at $9.8 million, down from $11.5 million in the prior quarter.
• The five-year high for Current Leases was $22.5 million in Q4 2017, with the low at $9.8 million in Q4 2018.
• Average Current Leases over 5 years is $17.1 million, with a median of $17.8 million recorded in 2014.
• Year-over-year, Current Leases jumped 120.71% in 2014 and plunged 56.43% in 2018.
• Tracing VRTX's Current Leases over 5 years: stood at $17.8 million in 2014, then slipped by 12.7% to $15.5 million in 2015, then gained by 24.97% to $19.4 million in 2016, then increased by 15.98% to $22.5 million in 2017, then sank by 56.43% to $9.8 million in 2018.
• The last three Current Leases figures came in at $9.8 million (Q4 2018), $11.5 million (Q3 2018), and $15.1 million (Q2 2018), per Business Quant data.

Peer Comparison